FDA Delays Decision on Alexza Antipsychotic Treatment
The U.S. Food and Drug Administration moved its decision date back by three months on Alexza Pharmaceuticals Inc.'s schizophrenia drug delivery system, citing the company's recent update to its new drug...To view the full article, register now.
Already a subscriber? Click here to view full article